Cleared Traditional

AccuContour

K221706 · Manteia Technologies Co., Ltd. · Radiology
Mar 2023
Decision
269d
Days
Class 2
Risk

About This 510(k) Submission

K221706 is an FDA 510(k) clearance for the AccuContour, a Radiological Image Processing Software For Radiation Therapy (Class II — Special Controls, product code QKB), submitted by Manteia Technologies Co., Ltd. (Xiamen, CN). The FDA issued a Cleared decision on March 9, 2023, 269 days after receiving the submission on June 13, 2022. This device falls under the Radiology review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K221706 FDA.gov
FDA Decision Cleared SESE
Date Received June 13, 2022
Decision Date March 09, 2023
Days to Decision 269 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code QKB — Radiological Image Processing Software For Radiation Therapy
Device Class Class II — Special Controls
CFR Regulation 21 CFR 892.2050
Definition To Provide Semi-automatic Or Fully-automated Radiological Image Processing And Analysis Tools For Radiation Therapy. Software Implementing Artificial Intelligence (ai) Including Nonadaptive Machine Learning Algorithms Trained With Clinical And/or Artificial Radiological Images. In These Devices, The Algorithm Training Images Typically Impact Device Performance. Ai Based Radiological Image Processing Software Is Intended To Be Used In The Workflow Of Radiation Therapy. Adaptive Ai Algorithms Are Not Within The Scope Of This Product Code. Primary Radiation Dose Calculation Or Plan Optimization For Treatment Planning Are Not Within Scope Of This Product Code.